MedPath

LENALIDOMIDA CIPLA 20 MG CAPSULAS DURAS EFG

LENALIDOMIDA CIPLA 20 MG CAPSULAS DURAS EFG

Pending
Register Number

84939

Prescription Type

Uso Hospitalario

Authorization Date

Mar 10, 2020

Dosage Form

CÁPSULA DURA

Route: VÍA ORAL

Product Details

Detailed information about this CIMA AEMPS approved pharmaceutical product.

Basic Information

Key regulatory and product classification details

Regulatory Details

Register Number84939
EMA Approved
No

Drug Classification

Generic
Yes
Orphan
No
Biosimilar
No
Commercialized
No
CIMA AEMPS Classification

INGREDIENTS (1)

LENALIDOMIDAActive
Quantity: 20 mg
Name: LENALIDOMIDA

ATC CLASSIFICATION (3)

L04A
L04AX
L04AX04

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.